You are browsing the archive for DRI Capital - peHUB.

DRI Capital Closes Second Drug Royalty Fund

Posted on: April 7, 2010 by PEHub AdministratorNo Comments »

DRI Capital, a private equity firm which invests in drug royalty streams, has closed its second fund with $701 million in capital commitments. It originally targeted $500 million, with Atlantic-Pacific Capital serving as placement agent.

DRI Crosses Fundraising Target, Doesn’t Stop

Posted on: March 30, 2010 by Erin GriffithNo Comments »

DRI Capital, a private equity firm which invests in drug royalty streams, has raised $600 million for its second fund, a source familiar with the situation said. The firm originally targeted $500 million for Drug Royalty II LP, but has continued to accept new commitments. DRI Capital’s first fund was a 2006 vintage with $800 [...]